Search research articles
Contact Us
Filters
Showing results (311-320 of 365) with videos related to
Page
of 37
Sort By:
The American Journal of Psychiatry
|
May 1, 1997
Effects of the cholecystokinin agonist pentagastrin in patients with generalized anxiety disorder
O Brawman-Mintzer, R B Lydiard, J Bradwejn, et al.
Archives of General Psychiatry
|
May 1, 1988
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment
J C Ballenger, G D Burrows, R L DuPont, et al.
Archives of General Psychiatry
|
May 1, 1988
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety
R Noyes, R L DuPont, J C Pecknold, et al.
The American Journal of Psychiatry
|
November 1, 1995
Body dysmorphic disorder in patients with anxiety disorders and major depression: a comorbidity study
O Brawman-Mintzer, R B Lydiard, K A Phillips, et al.
The Journal of Clinical Psychiatry
|
August 24, 1999
The economic burden of anxiety disorders in the 1990s
P E Greenberg, T Sisitsky, R C Kessler, et al.
The Psychiatric Clinics of North America
|
January 9, 2001
Vagus nerve stimulation. A potential therapy for resistant depression?
M S George, H A Sackeim, L B Marangell, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
October 1, 1995
Long-term follow-up after a drug trial for panic disorder
H Katschnig, M Amering, J M Stolk, et al.
Alcoholism, Clinical and Experimental Research
|
July 9, 1999
Multiple previous alcohol detoxifications are associated with decreased medial temporal and paralimbic function in the postwithdrawal period
M S George, C C Tenebäck, R J Malcolm, et al.
The Journal of Clinical Psychiatry
|
January 20, 2004
Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety
James C Ballenger, Jonathan R T Davidson, Yves Lecrubier, et al.
Advances in Biochemical Psychopharmacology
|
January 11, 1992
The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist, abecarnil (ZK 112-119), in generalized anxiety disorder
J C Ballenger, S McDonald, R Noyes, et al.
Page
of 37
Search research articles
Search
Showing results (311-320 of 365) with videos related to
Sort By:
Page
of 37
The American Journal of Psychiatry
|
May 1, 1997
Effects of the cholecystokinin agonist pentagastrin in patients with generalized anxiety disorder
O Brawman-Mintzer, R B Lydiard, J Bradwejn, et al.
Archives of General Psychiatry
|
May 1, 1988
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment
J C Ballenger, G D Burrows, R L DuPont, et al.
Archives of General Psychiatry
|
May 1, 1988
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety
R Noyes, R L DuPont, J C Pecknold, et al.
The American Journal of Psychiatry
|
November 1, 1995
Body dysmorphic disorder in patients with anxiety disorders and major depression: a comorbidity study
O Brawman-Mintzer, R B Lydiard, K A Phillips, et al.
The Journal of Clinical Psychiatry
|
August 24, 1999
The economic burden of anxiety disorders in the 1990s
P E Greenberg, T Sisitsky, R C Kessler, et al.
The Psychiatric Clinics of North America
|
January 9, 2001
Vagus nerve stimulation. A potential therapy for resistant depression?
M S George, H A Sackeim, L B Marangell, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
October 1, 1995
Long-term follow-up after a drug trial for panic disorder
H Katschnig, M Amering, J M Stolk, et al.
Alcoholism, Clinical and Experimental Research
|
July 9, 1999
Multiple previous alcohol detoxifications are associated with decreased medial temporal and paralimbic function in the postwithdrawal period
M S George, C C Tenebäck, R J Malcolm, et al.
The Journal of Clinical Psychiatry
|
January 20, 2004
Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety
James C Ballenger, Jonathan R T Davidson, Yves Lecrubier, et al.
Advances in Biochemical Psychopharmacology
|
January 11, 1992
The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist, abecarnil (ZK 112-119), in generalized anxiety disorder
J C Ballenger, S McDonald, R Noyes, et al.
Page
of 37